354 related articles for article (PubMed ID: 36483548)
1. Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study.
Wang MG; Wu SQ; Zhang MM; He JQ
Front Immunol; 2022; 13():1002126. PubMed ID: 36483548
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal metabolomics of human plasma reveal metabolic dynamics and predictive markers of antituberculosis drug-induced liver injury.
Li M; Zhang D; Yang Q; Zhao Z; Zhang C; Zhou Y; Bai Y; Chen L; Tang X; Liu C; Zhou J; Chen X; Ying B
Respir Res; 2024 Jun; 25(1):254. PubMed ID: 38907347
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury.
Wang MG; Wu SQ; Zhang MM; He JQ
Front Pharmacol; 2022; 13():1044808. PubMed ID: 36386176
[No Abstract] [Full Text] [Related]
4. Serum levels of IL-6/IL-10/GLDH may be early recognition markers of anti-tuberculosis drugs (ATB) -induced liver injury.
Xiang HR; Li Y; Cheng X; He B; Li HM; Zhang QZ; Wang B; Peng WX
Toxicol Appl Pharmacol; 2023 Sep; 475():116635. PubMed ID: 37487937
[TBL] [Abstract][Full Text] [Related]
5. Relevance of
Cheng F; Qiu CC; Jiang XG; Wu T; Zhang Q; Chen X; Zheng SL; Liu SD; Ye XC; Shi JC
Pharmacogenomics; 2024 Jan; 25(1):21-28. PubMed ID: 38131213
[TBL] [Abstract][Full Text] [Related]
6. [Nomogram model for predicting risk of anti-tuberculosis drug-induced liver injury among inpatients with tuberculosis].
Zhao P; Chen J; Yang YQ; Peng Y
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Feb; 45(2):171-176. PubMed ID: 35135086
[No Abstract] [Full Text] [Related]
7. Lipid peroxidation aggravates anti-tuberculosis drug-induced liver injury: Evidence of ferroptosis induction.
Pan Y; Tang P; Cao J; Song Q; Zhu L; Ma S; Zhang J
Biochem Biophys Res Commun; 2020 Dec; 533(4):1512-1518. PubMed ID: 33121683
[TBL] [Abstract][Full Text] [Related]
8. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the predictive outcomes for anti-tuberculosis drug-induced hepatotoxicity by different machine learning techniques.
Lai NH; Shen WC; Lee CN; Chang JC; Hsu MC; Kuo LN; Yu MC; Chen HY
Comput Methods Programs Biomed; 2020 May; 188():105307. PubMed ID: 31911332
[TBL] [Abstract][Full Text] [Related]
10. First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform.
Cao J; Mi Y; Shi C; Bian Y; Huang C; Ye Z; Liu L; Miao L
Biochem Biophys Res Commun; 2018 Mar; 497(2):485-491. PubMed ID: 29454961
[TBL] [Abstract][Full Text] [Related]
11. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
[TBL] [Abstract][Full Text] [Related]
12. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
13. The effect of statins on the risk of anti-tuberculosis drug-induced liver injury among patients with active tuberculosis: A cohort study.
Huang CK; Huang JY; Chang CH; Tsai SJ; Shu CC; Wang HC; Chien KL
J Microbiol Immunol Infect; 2024 Jun; 57(3):498-508. PubMed ID: 38632021
[TBL] [Abstract][Full Text] [Related]
14. Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury.
Huang D; Peng J; Lei L; Chen Y; Zhu Z; Cai Q; Deng Y; Chen J
J Clin Transl Hepatol; 2023 Apr; 11(2):425-432. PubMed ID: 36643044
[TBL] [Abstract][Full Text] [Related]
15. Patients with tuberculous meningitis and hepatitis B co-infection have increased risk for antituberculosis drug-induced liver injury and poor outcomes.
Mo X; Xu X; Ren Z; Guan J; Peng J
Infect Dis (Lond); 2020 Nov; 52(11):793-800. PubMed ID: 32619380
[TBL] [Abstract][Full Text] [Related]
16. Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment.
Ho CM; Chen CL; Chang CH; Lee MR; Wang JY; Hu RH; Lee PH
Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440095
[TBL] [Abstract][Full Text] [Related]
17. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
Teschke R; Danan G
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
[TBL] [Abstract][Full Text] [Related]
18. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.
Teschke R
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047633
[TBL] [Abstract][Full Text] [Related]
19. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
20. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis.
Chou C; Veracruz N; Chitnis AS; Wong RJ
J Viral Hepat; 2022 Dec; 29(12):1107-1114. PubMed ID: 36138556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
